Despite being federally legal, CBD companies still have problems obtaining capital and standard services from banks and other financial services institutions. The ability to market CBD as a safe and effective substance is limited by how the FDA classifies it. CBD is considered a drug by the FDA and therefore may not by sold for […]
Despite being federally legal, non-prescription CBD companies still have problems obtaining capital and standard services from banks and other financial services institutions. The ability to market CBD as a safe and effective substance is limited by how the FDA presently classifies it–i.e. CBD is classified as a drug and therefore is prohibited unless specifically approved […]
Sept. 20, 2022: Fentanyl is now the leading cause of death in adults (ages 18-45) in the United States. The CDC reported that fentanyl comprises the largest cause by percentage of all drug overdose deaths with 37,208 fentanyl deaths for 2020 and 41,587 deaths for 2021–an almost 12% increase in one year–of the total deaths […]
HEMPINDUSTRYDAILY (WEB) AUGUST 12, 2021 Federal health regulators have rejected the sale of full-spectrum CBD as a dietary supplement, a signal that CBD products will remain legal under federal law only by prescription in the U.S. The Food and Drug Administration announced the decision this week in letters to CBD makers Charlotte’s Web of Colorado and […]
Annual MRI examinations are currently estimated at 40 million in the Unites States. Cataract operations in the U.S. numbered 4.4 million last year.
In late December of 2020, the Australian Therapeutic Goods Agency (TGA), the regulatory equivalent of the Food and Drug Administration (FDA), determined that naturally extracted hemp oil CBD could be sold over-the-counter in pharmacies. Once a given product has submitted for approval it must first be determined as both safe and effective through a series […]